基于机器学习的新型疫苗设计程序AutoPepVax:应用于针对EGFR误解突变的泛癌疫苗
Enrico Bautista1, Young Hyun Jung2, Manuela Jaramillo3
1Georgetown University School of Medicine, Washington, DC 20007, USA.
Pharmaceuticals (Basel, Switzerland)
|April 27, 2024
概括
自动PepVax是通过识别安全有效的表位体来设计疫苗的新工具. 它分析突变,如表皮生长因子受体 (EGFR) 的突变,以创建具有广泛人口覆盖的潜在泛癌疫苗.
科学领域:
- 计算生物学是一种计算生物学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 目前的类疫苗设计在很大程度上依赖于预测表位组结合亲和力.
- 需要先进的in silico方法来识别免疫学相关的表位,以提高疫苗的疗效.
研究的目的:
- 开发AutoPepVax,这是一个用于在疫苗设计中加速和增强in silico表位元选择的新型程序.
- 为了识别能够诱导瘤透淋巴细胞的非有毒,非过敏性表位.
主要方法:
- AutoPepVax使用在瘤样本数据上训练的机器学习模型 (随机森林分类,线性回归).
- 它分析了各种表位特征,包括诱导瘤透淋巴细胞的潜力.
- 该计划被用来设计一种泛癌类疫苗,针对表皮生长因子受体 (EGFR) 突变.
主要成果:
- 自动PepVax从EGFR突变中确定了368个潜在的MHC-I和430个潜在的MHC-II受限表位-HLA对.
- 19个突变产生了MHC I和II限制的可活性表位.
- 一个精心策划的表位列表实现了MHCII类和I类的全球人口覆盖率分别为81.8%至98.5%.
结论:
- AutoPepVax提供了一种全面的 in silico 表位选择方法,解决类疫苗的安全性,有效性和广泛适用性.
- 开发的泛癌疫苗策略显示了针对常见EGFR突变的巨大潜力.
- 未来的研究将涉及在临床前的小鼠瘤模型中验证AutoPepVax设计的疫苗.
关键词:
针对EGFR疫苗的设计在MHC I和II的MHC I和II.T-细胞受体的受体.标志性表现物 (Epitopes) 是一种表现物.机器学习用于类疫苗设计.新的疫苗设计方法面部癌症疫苗 面部癌症疫苗更多相关视频
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.2K
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
